Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124322832 | 12432283 | 2 | F | 20160427 | 20160526 | 20160603 | 20160920 | PER | US-ELI_LILLY_AND_COMPANY-US201605006838 | ELI LILLY AND CO | 50.00 | YR | F | Y | 0.00000 | 20160920 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124322832 | 12432283 | 1 | PS | ADCIRCA | TADALAFIL | 1 | Unknown | UNK, UNKNOWN | U | U | 21368 | TABLET | |||||||
| 124322832 | 12432283 | 2 | SS | AMBRISENTAN | AMBRISENTAN | 1 | Unknown | 5 MG, QD | U | U | SBFS | 0 | 5 | MG | QD | ||||
| 124322832 | 12432283 | 3 | SS | ORENITRAM | TREPROSTINIL | 1 | Unknown | 3.5 MG, TID | U | U | 0 | 3.5 | MG | TID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124322832 | 12432283 | 1 | Product used for unknown indication |
| 124322832 | 12432283 | 2 | Pulmonary hypertension |
| 124322832 | 12432283 | 3 | Pulmonary arterial hypertension |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124322832 | 12432283 | Cough | |
| 124322832 | 12432283 | Nasopharyngitis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |